Z. Dave Sharp

9.6k citations

68 papers · 7.3k indexed · 4 hit papers · h-index 27

Aging top 0.05%
- Genetics, Aging, and Longevity in Model Organisms 16
Geriatrics and Gerontology top 0.5%
Endocrine and Autonomic Systems top 1%
- Circadian rhythm and melatonin 7
Physiology top 1%
Molecular Biology top 1%
- Genomics and Chromatin Dynamics 13
- CRISPR and Genetic Engineering 10
- RNA Research and Splicing 10
- PI3K/AKT/mTOR signaling in cancer 8
Endocrinology, Diabetes and Metabolism
- Growth Hormone and Insulin-like Growth Factors 12
Genetics
- Estrogen and related hormone effects 7

Co-authors: Randy Strong Martin A. Javors James F. Nelson Nancy L. Nadon Richard A. Miller Elizabeth Fernández Kevin Flurkey Clinton M. Astle
Cited by: Aging Geriatrics and Gerontology Endocrine and Autonomic Systems
Journals: Molecular and Cellular Biology (6 papers)The Journals of Gerontology Series A (5 papers)Journal of Biological Chemistry (4 papers)
Partner nations: United States Canada Czechia

In The Last Decade

Z. Dave Sharp

68 papers receiving 7.2k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Z. Dave Sharp

Since Specialization

Citations

This map shows the geographic impact of Z. Dave Sharp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Z. Dave Sharp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Z. Dave Sharp more than expected).

Fields of papers citing papers by Z. Dave Sharp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Z. Dave Sharp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Z. Dave Sharp. The network helps show where Z. Dave Sharp may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Z. Dave Sharp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Z. Dave Sharp Line = papers co-authored together Z. Dave Sharp links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Rapamycin, the only drug that has been consistently demonstrated to increase mammalian longevity. An update Experimental Gerontology ·Z. Dave Sharp,Randy Strong	2023	22
2	Rapamycin Extends Life Span in Apc Colon Cancer FAP Model Clinical Colorectal Cancer ·M. V. Shilov,Sherry G. Dodds,Gene B. Hubbard,Martin A. Javors,Randy Strong,Paul Hasty,Z. Dave Sharp	2020	23
3	Sex-dependent lifespan extension of ApcMin/+ FAP mice by chronic mTOR inhibition PubMed ·M. V. Shilov,Sherry G. Dodds,Timothy D. Dale,Randy Strong,Paul Hasty,Z. Dave Sharp	2020	9
4	Rapamycin Prevents Surgery-Induced Immune Dysfunction in Patients with Bladder Cancer Cancer Immunology Research ·Robert S. Svatek,Niannian Ji,Getasew Gashaw Molla,Neelam Mukherjee,ANANDA CYNTIA DWI,Vincent Hurez,Marlo Nicolas,Joel Michalek,Martin A. Javors,Karen Wheeler,Z. Dave Sharp,Carolina B. Livi,Pathik Wadwha,Yong Meng,Tyler J. Curiel	2018	20
5	Prevention of Carcinogen and Inflammation-Induced Dermal Cancer by Oral Rapamycin Includes Reducing Genetic Damage Cancer Prevention Research ·Vinh Dao,Srilakshmi Pandeswara,Anthony N. Laskovski,Vincent Hurez,Sherry G. Dodds,Danielle Callaway,Aijie Liu,Paul Hasty,Z. Dave Sharp,Tyler J. Curiel	2015	16
6	Chronic mTOR inhibition in mice with rapamycin alters T , B , myeloid, and innate lymphoid cells and gut flora and prolongs life of immune‐deficient mice Aging Cell ·Vincent Hurez,Vinh Dao,Aijie Liu,Srilakshmi Pandeswara,Jonathan Gelfond,Lishi Sun,Molly A. Bergman,Carlos J. Orihuela,Verónica Galván,Álvaro Padrón,Justin Drerup,Yang Liu,Paul Hasty,Z. Dave Sharp,Tyler J. Curiel	2015	98
7	Spatiotemporal control of estrogen-responsive transcription in ERα-positive breast cancer cells Oncogene ·Yandie Pan,Mark Shimazaki,H. Walenda,Haw-Soon Lim,Eunice S. Wang,R T Opal,Ismail Jatoi,Jiali Zeng,Nameer B. Kirma,Victor X. Jin,Z. Dave Sharp,George Okyere Dokyi	2015	12
8	Senescent Cells Contribute to the Physiological Remodeling of Aged Lungs The Journals of Gerontology Series A ·Н.А. Новиков,Pooja Shivshankar,Mirna Saker,Lauren Sloane,Carolina B. Livi,Z. Dave Sharp,Carlos J. Orihuela,Serge Adnot,Eric S. White,Arlan Richardson,Claude Jourdan Le Saux	2015	65
9	Rapamycin‐mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction Aging Cell ·Richard A. Miller,David E. Harrison,Clinton M. Astle,Elizabeth Fernández,Kevin Flurkey,Melissa Han,Martin A. Javors,Xinna Li,Nancy L. Nadon,James F. Nelson,Scott D. Pletcher,Adam B. Salmon,Z. Dave Sharp,智登西川,R. Chmielecki,Randy Strong	2013	430
10	eRapa Restores a Normal Life Span in a FAP Mouse Model Cancer Prevention Research ·Paul Hasty,Carolina B. Livi,Sherry G. Dodds,D.R. Jones,Randy Strong,Martin A. Javors,Kathleen E. Fischer,Lauren Sloane,Kruthi Murthy,Gene B. Hubbard,Lishi Sun,Vincent Hurez,Tyler J. Curiel,Z. Dave Sharp	2013	56
11	The Role of mTOR Signaling in Controlling Mammalian Life Span: What a Fungicide Teaches Us About Longevity The Journals of Gerontology Series A ·Z. Dave Sharp,Randy Strong	2010	40
12	Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Micebreakdown → The Journals of Gerontology Series A ·Richard A. Miller,(unknown),Clinton M. Astle,Joseph A. Baur,Angela R. Boyd,Rafael de Cabo,Elizabeth Fernández,Kevin Flurkey,Martin A. Javors,James F. Nelson,Carlos J. Orihuela,Scott D. Pletcher,Z. Dave Sharp,David Sinclair,Joseph W. Starnes,John E. Wilkinson,Nancy L. Nadon,Randy Strong	2010	686
13	Aging and TOR: interwoven in the fabric of life Cellular and Molecular Life Sciences ·Z. Dave Sharp	2010	26
14	Ligand-induced large-scale chromatin dynamics as a biosensor for the detection of estrogen receptor subtype selective ligands Gene ·Rocio Garcı́a-Becerra,Valeria Berno,David Ordaz‐Rosado,Z. Dave Sharp,Austin J. Cooney,Michael A. Mancini,Fernando Larrea	2010	5
15	Design of aging intervention studies: the NIA interventions testing program AGE ·Nancy L. Nadon,Randy Strong,Richard A. Miller,James F. Nelson,Martin A. Javors,Z. Dave Sharp,Josep Maria Peralba,(unknown)	2008	110
16	Application of Exogenously Regulatable Promoter Systems to Transgenic Models for the Study of Aging The Journals of Gerontology Series A ·W. W. Morgan,Arlan Richardson,Z. Dave Sharp,Christi A. Walter	1999	17
17	Binding of CtIP to the BRCT Repeats of BRCA1 Involved in the Transcription Regulation of p21 Is Disrupted Upon DNA Damage Journal of Biological Chemistry ·Shang Li,Phang‐Lang Chen,W. A. Nash,G. Chinnadurai,Gail E. Tomlinson,C. Kent Osborne,Z. Dave Sharp,Wen‐Hwa Lee	1999	167
18	3.6 kb of the 5′ Flanking DNA Activates the Mouse Tyrosine Hydroxylase Gene Promoter Without Catecholaminergic‐Specific Expression Journal of Neurochemistry ·W. W. Morgan,Christi A. Walter,Jolene J. Windle,Z. Dave Sharp	1996	17
19	DNA recognition element required for PUF-I mediated cell-type-specific transcription of the rat prolactin gene Nucleic Acids Research ·Z. Dave Sharp,L. Wilhelmsen,Zhaodan Cao,Mariella García-Caputi,Yolanda Sánchez	1989	16
20	Vasoactive Intestinal Peptide Increases Prolactin Messenger Ribonucleic Acid Content in GH3 Cells* Endocrinology ·Alberto J. Carrillo,Thomas B. Pool,Z. Dave Sharp	1985	52

About Z. Dave Sharp

Z. Dave Sharp is a scholar working on Aging, Endocrine and Autonomic Systems and Endocrinology, Diabetes and Metabolism, having authored 68 papers that have together received 7.3k indexed citations. Recurring topics across this work include Genetics, Aging, and Longevity in Model Organisms (16 papers), Genomics and Chromatin Dynamics (13 papers), Growth Hormone and Insulin-like Growth Factors (12 papers), CRISPR and Genetic Engineering (10 papers), RNA Research and Splicing (10 papers), PI3K/AKT/mTOR signaling in cancer (8 papers), Circadian rhythm and melatonin (7 papers) and Estrogen and related hormone effects (7 papers). The work is most often cited by research in Aging (2.2k citations), Geriatrics and Gerontology (431 citations) and Endocrine and Autonomic Systems (708 citations). Z. Dave Sharp has collaborated with scholars based in United States, Canada and Czechia. Frequent co-authors include Randy Strong, Martin A. Javors, James F. Nelson, Nancy L. Nadon, Richard A. Miller, Elizabeth Fernández, Kevin Flurkey, Clinton M. Astle, John E. Wilkinson and Phang‐Lang Chen. Their work appears in journals such as Molecular and Cellular Biology, The Journals of Gerontology Series A, Journal of Biological Chemistry, Journal of Cellular Biochemistry and Aging Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact